Dakota Wealth Management Edwards Lifesciences Corp Transaction History

Dakota Wealth Management

$4.35 Billion
Q3 2024

A detailed history of Dakota Wealth Management transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Dakota Wealth Management holds 5,877 shares of EW stock, worth $443,008. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,877

Previous 14,443 59.31%

Holding current value

$443,008

Previous $1.33 Million 70.99%

% of portfolio

0.01%

Previous 0.03%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$59.7 - $93.78 $511,390 - $803,319	-8,566 Reduced 59.31%	5,877 $387,000
Q2 2024 Jul 19, 2024	SELL	$84.3 - $94.31 $32,286 - $36,120	-383 Reduced 2.58%	14,443 $1.33 Million
Q1 2024 Apr 24, 2024	BUY	$72.54 - $95.56 $241,485 - $318,119	3,329 Added 28.96%	14,826 $1.42 Million
Q4 2023 Jan 30, 2024	SELL	$61.71 - $77.76 $112,744 - $142,067	-1,827 Reduced 13.71%	11,497 $876,000
Q3 2023 Oct 23, 2023	BUY	$69.28 - $93.38 $56,463 - $76,104	815 Added 6.52%	13,324 $923,000
Q2 2023 Jul 31, 2023	BUY	$81.41 - $94.33 $463,304 - $536,832	5,691 Added 83.47%	12,509 $1.18 Million
Q1 2023 Apr 14, 2023	BUY	$74.26 - $84.51 $445 - $507	6 Added 0.09%	6,818 $564,000
Q4 2022 Feb 07, 2023	SELL	$68.3 - $87.44 $37,838 - $48,441	-554 Reduced 7.52%	6,812 $508,000
Q3 2022 Nov 10, 2022	SELL	$82.37 - $107.29 $708,793 - $923,230	-8,605 Reduced 53.88%	7,366 $609,000
Q2 2022 Aug 05, 2022	SELL	$86.5 - $128.27 $1.14 Million - $1.7 Million	-13,217 Reduced 45.28%	15,971 $1.52 Million
Q1 2022 May 13, 2022	BUY	$101.96 - $128.34 $75,144 - $94,586	737 Added 2.59%	29,188 $3.44 Million
Q4 2021 Feb 10, 2022	BUY	$106.37 - $130.68 $258,372 - $317,421	2,429 Added 9.33%	28,451 $3.69 Million
Q3 2021 Nov 15, 2021	BUY	$102.91 - $122.75 $231,444 - $276,064	2,249 Added 9.46%	26,022 $2.95 Million
Q2 2021 Aug 02, 2021	SELL	$83.84 - $104.76 $119,555 - $149,387	-1,426 Reduced 5.66%	23,773 $2.46 Million
Q1 2021 May 10, 2021	SELL	$78.68 - $90.67 $508,508 - $586,000	-6,463 Reduced 20.41%	25,199 $2.11 Million
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $32,260 - $41,053	450 Added 1.44%	31,662 $2.89 Million
Q3 2020 Nov 04, 2020	BUY	$67.19 - $87.44 $1.52 Million - $1.97 Million	22,560 Added 260.75%	31,212 $2.49 Million
Q2 2020 Aug 07, 2020	BUY	$57.54 - $76.95 $328,841 - $439,769	5,715 Added 194.59%	8,652 $598,000
Q1 2020 Apr 29, 2020	BUY	$52.41 - $81.0 $153,928 - $237,897	2,937 New	2,937 $554,000

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

457M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.6B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dakota Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Dakota Wealth Management with notifications on news.

Account

Dakota Wealth Management Edwards Lifesciences Corp Transaction History